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Hepatitis B virus (HBV) is one of the major viruses causing acute hepatitis.  Recently,  the incidence of 
acute hepatitis with genotype A has been increasing in Japan.  The aim of this study was to investigate 
acute hepatitis B (AHB) in Okayama prefecture,  with special attention to HBV genotype A.  AHB 
patients who visited one of 12 general hospitals in Okayama prefecture between 2006 and 2010 were 
retrospectively analyzed.  Over the course of the study period,  128 patients were diagnosed with AHB.  
Sexual transmission was supposed in the majority of patients (78 patients,  61ｵ),  including 59 (76ｵ) 
having sex with heterosexual partners.  The genotypes of HBV were assessed in 90 patients (70ｵ),  of 
whom 27 patients were infected with genotype A,  5 with genotype B,  and 58 with genotype C.  The 
prevalence of genotype A was signiﬁcantly higher among male patients (28.7ｵ),  aged 20-29 (35.6ｵ,  
p＜0.01),  among men who had sex with men (100ｵ,  p＜0.005),  and among patients having sex with 
unspeciﬁed partners (44.8ｵ,  p＜0.005).  Genotype A was not a signiﬁcant factor associated with 
delayed HBsAg disappearance.  Caution should be exercised with regard to sexually transmissible dis-
eases in order to slow the pandemic spread of AHB due to genotype A.
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epatitis B virus (HBV) is one of the major 
viruses causing acute hepatitis.  In Japan,  the 
causative viruses during the 1990s were the HBV 
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genotypes B and C [1].  Recently,  however,  acute 
hepatitis due to HBV genotype A has been increasing 
in large metropolitan areas such as Tokyo or Osaka in 
Japan,  where it is assumed to have been imported 
from outside Japan [2].  When adults are infected 
with HBV,  acute hepatitis due to HBV genotypes B 
and C can generally be cured,  while 10ｵ of acute 
hepatitis cases due to HBV genotype A become 
chronic [3].  The incidence of chronicity is especially 
high in patients co-infected with HBV and human 
immunodeﬁciency virus (HIV).
　 Among hepatitis cases in Japan,  that portion with 
acute viral hepatitis due to HBV genotype A was 6.0ｵ 
between 1991 and 1996 but has expanded since 2000,  
to reach 52ｵ in 2008 [4].  The Ministry of Health,  
Labor and Welfare has started an epidemiological 
investigation of the prevalence of acute or chronic 
hepatitis due to HBV genotype A,  undertaken by a 
study group on the natural history of HBV genotype 
A.  The aim of the present study was to investigate 
acute hepatitis due to HBV in Okayama prefecture,  
with special attention to HBV genotype A.
Materials and Methods
　 Patients. There are 12 general hospitals in 
Okayama prefecture that possess 300 or more beds for 
in-patient care.  All patients who visited one of these 
hospitals and had a diagnosis of acute hepatitis B 
(AHB) between 2006 and 2010 were retrospectively 
analyzed.  AHB was diagnosed by the results of ele-
vated titer of anti-IgM HBc antibody and the exclusion 
of patients who may have had chronic HBV infection.  
Patients with drug-induced liver injury,  alcoholic liver 
injury and autoimmune hepatitis were excluded from 
the study.  Information regarding the cause and place 
of infection,  HBV genotype,  the positivity of the anti-
HIV antibody,  and the use of nucleotide analogues in 
the treatment of acute hepatitis,  was collected from 
all patients.  The study was performed in accordance 
with the Helsinki Declaration and was approved by the 
ethical committees of all participating institutions.
　 Statistical analysis. Data are expressed as 
means ± standard deviations.  Patient characteristics 
were compared among groups using the Mann-Whitney 
U test or Kruskal-Wallis test.  Factors associated 
with the presence of Hepatitis B surface antigen 
(HBsAg) 12 months after the diagnosis (i.e.,  persis-
tence) were analyzed by stepwise logistic regression 
analysis.  Negativity of HBsAg was presumed by using 
the Kaplan-Meier method,  and the results among 
groups were compared with the log rank test.  P val-
ues ＜0.05 were considered to indicate signiﬁcance.
Results
　 Patient characteristics of the patients with 
acute hepatitis B. A total of 128 patients were 
diagnosed with AHB at the 12 participating hospitals 
between 2006 and 2010; the incidence of AHB was 
between 20 and 30 cases annually (Fig.  1).  Eighty-
seven patients (68ｵ) were male,  and the peak age was 
between 20 and 29 (45 patients,  35ｵ).  Ten patients 
were 60 or older.  Sexual transmission had caused the 
viral infection in the majority of patients (78 patients,  
61ｵ),  including 59 patients (76ｵ) having sex with 
heterosexual partners and 4 male patients getting 
infected from homosexual partners.  Forty-two patients 
got infected from a speciﬁed partner (54ｵ),  and 9 
patients from non-Japanese partners (12ｵ).  Tattooing 
and needle stick accidents were suspected as the 
causes of viral infection for one and 4 patients,  
respectively.  The places of viral infection were some-
where in Okayama prefecture for 31 patients (40ｵ),  
other places than Okayama in Japan for 10 patients 
(13ｵ),  and Southeast Asian countries during travels 
for 8 patients (10ｵ).  Anti-hepatitis C virus antibody 
was tested for in 124 patients (97ｵ),  and 3 patients 
had positive results,  while anti-HIV antibody was 
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Fig. 1　 Annual incidence of AHB between 2006 and 2010.  The 
incidence of AHB was between 20 and 30 annually between 2006 
and 2010.
examined in only 68 patients (53ｵ),  with positive 
results for 2 patients.  One male patient in his 20s may 
have been infected by sex with an unspeciﬁed female 
partner.  His HBV genotype was not assessed.  The 
other was a male in his 20s who had sex with unspeci-
ﬁed men in Fukuoka prefecture,  and got infected with 
HBV genotype A.
　 Prevalence of HBV genotype A in patients 
with AHB. As shown in Fig.  2,  the genotypes of 
HBV were assessed in 90 patients (70ｵ); 27 patients 
were infected with HBV genotype A (21ｵ),  5 with 
HBV genotype B (4ｵ),  and 58 with HBV genotype C 
(45ｵ).  The percentages of HBV genotype A did not 
change much over the 5-year study period.  The 
prevalence of HBV genotype A was signiﬁcantly 
higher among male patients (25 patients,  28.7ｵ) than 
females (2 patients,  4.9ｵ,  p＜0.005),  among those 
aged 20-29 (16 patients,  35.6ｵ,  p＜0.01),  among 
men who had sex with men (4 patients,  100ｵ,  p＜
0.005),  and among patients having sex with unspeciﬁed 
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Fig. 2　 Comparison of patient characteristics.  HBV genotype A,  black; B,  slashed; C,  striped; not analyzed,  meshed.  The preva-
lence of HBV genotype A was signiﬁcantly higher among male patients (28.7%) than females (4.9%,  p＜0.005,  A),  and in those aged 
20-29 (35.6%,  p＜0.01,  B).  All the patients among the men who had sex with men developed acute hepatitis with HBV genotype A 
(100%,  p＜0.005,  C),  Among the patients having sex with unspeciﬁed partners and with acute hepatitis,  half (44.8%) had HBV genotype 
A (p＜0.005,  C).  HBV genotype A transmission was found to occur both within and outside of Okayama prefecture.
partners (13 patients,  44.8ｵ,  p＜0.005).  About half 
of the patients (9 patients) with HBV genotype A got 
infected in Okayama prefecture.  These results sug-
gest that HBV genotype A is already prevalent in 
Okayama prefecture.  There were no signiﬁcant diﬀer-
ences in clinical characteristics such as total bilirubin,  
alanine aminotransferase,  or prothrombin time among 
the patient groups with the diﬀerent HBV genotypes.
　 Negativity of HBs antigen. HBsAg became 
negative in all cases,  as shown in Fig.  3A.  The 
median time for negative testing after the initial diag-
nosis was 4 months; the maximum time was 24 months.  
Factors associated with negativity of HBsAg within 6 
months after diagnosis were investigated but no sig-
niﬁcant factor was found.  Some patients with HBV 
genotype A achieved negative HBsAg more slowly than 
those with HBV genotype B or C,  but this diﬀerence 
was not signiﬁcant (Fig.  3B,  p＝0.20).
　 A notiﬁcation at a health center. According 
to the infectious diseases control law of Japan in 
1999,  acute hepatitis due to HBV has been classiﬁed 
as a category V infectious disease,  with the diagnosis 
requiring reports to the local public health center for 
all cases within 1 week.  Despite this requirement the 
number of notiﬁcations made by institutions in 
Okayama from 2006 to 2010 was only 36.
Discussion
　 We retrospectively investigated AHB cases in 
Okayama prefecture from 2006 to 2010,  and have 
summarized the characteristics of the patients with 
HBV genotype A.  Though the analysis of HBV geno-
type was not covered by Japanese national health 
insurance until 2011,  70ｵ of HBV patients were 
analyzed for genotype.  The most common genotype 
remains genotype C,  but the second most common in 
Okayama prefecture has become genotype A,  replac-
ing genotype B.
　 The transmission route of genotype A HBV in 
recent years has included sexual transmission from a 
committed,  non-foreign heterosexual partner as well 
as that from homosexual,  foreign and unspeciﬁed 
heterosexual partners [5].  It is noteworthy that a 
similar pattern has appeared in Okayama prefecture,  
reﬂecting the pandemic spread of HBV genotype A to 
the general population from the speciﬁc groups of men 
who have sex with men.
　 As far as our investigations of AHB diagnosed 
within Okayama prefecture,  all patients eventually 
achieved HBsAg negativity,  with HBsAg positivity at 
6 months after diagnosis found in only 21ｵ of 
patients.  Delayed HBsAg disappearance was observed 
in some patients with AHB due to HBV genotype A,  
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Fig. 3　 Cumulative rates of serum HBsAg disappearance.  A,  shows cumulative rates of serum HBsAg disappearance.  The median 
persistence of HBsAg was 4 months after diagnosis.  Eight percent of patients retained HBsAg positivity for more than 12 months.  B,  
shows the cumulative rates of HBsAg disappearance by HBV genotypes.  There was no signiﬁcant diﬀerence in the rates of HBsAg disap-
pearance between the patients with HBV genotype A and others.  HBV genotype A,  solid line; HBV genotype B and C,  dotted line.
as compared with those due to HBV genotype B or C.  
Though Ito et al. reported that AHB due to HBV 
genotype A was associated with viral persistence [6],  
our data for that trend were not statistically signiﬁ-
cant.  This might be due to the small number of 
patients in our study and slightly insuﬃcient follow-up.
　 In the circumstance of chronic persistence,  report-
ing to a health center is especially important for 
national surveillance.  Clinicians should take care of 
this responsibility.
　 In conclusion,  a retrospective study of AHB diag-
nosed in Okayama between 2006 and 2010 was under-
taken.  The majority of patients with AHB were 
infected with the HBV genotype C,  although it was 
observed that AHB due to HBV genotype A in 
Okayama prefecture was now being contracted through 
sex with heterosexual partners.  Caution regarding 
sexually transmissible diseases is needed to prevent 
the pandemic spread of AHB due to HBV genotype A.
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